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591, 1980.--The specific activity of cerebral histamine N-methyltransferase (HMT) was significantly lower in the 
audiogenic seizure-susceptible (SS) 21-day old DBA/2J mouse when compared to the non-susceptible 70-day old DBA/2J 
mouse but not when compared to the seizure-resistant (SR) C57B1/6J mouse at 21 days of age. There was no significant 
difference between the two strains at 70 days of age. The lower HMT specific activity was also observed in a SS mutant of 
the deermouse Peromyscus maniculatus, relative to the SR, wild-type animal. The activity of cerebral catechol-O- 
methyltransferase (COMT) was significantly lower in the DBA/2J mice relative to the C57Bi/6J at 21 and 70 days while, in 
Peromyscus, it was higher in the SS mutant than in the SR animal. The activity of MAO, B was lower in the 21-day old, 
relative to the 70-day old DBA/2J and the 21-day old C57BI/6J mice. There were no differences in MAO A or B between SS 
and SR Peromyscus. The findings raise the possibility that cerebral methylation may operate at characteristic rates in SS 
animals. 
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RECENT evidence obtained in our laboratory points to the 
involvement of methylation in the cellular response of brain 
tissue to the convulsant agent L-methionine-dl-sulfoximine 
(MSO) [14,15]. Both the in vivo methylation of  cerebral his- 
tamine by histamine N-methyltransferase (HMT) [16] and 
the methylation of transfer ribonucleic acids (tRNA) by cer- 
ebral tRNA-methyltransferases [3,13] appear  to be signifi- 
cantly elevated [13,16] and the substrate specificity of  some 
of  the indiviudal tRNA methyltransferases [3] altered in the 
epileptogenic MSO brain. These observations have raised 
the possibility that methyl group transfer reactions operate in 
the MSO epileptogenic brain cells at characteristic levels, 
possibly "marking"  the preconvulsant state biochemically. 
In an attempt to ascertain the involvement of methyl 
group transfer reactions in an animal model with a geneti- 
cally determined, rather than a chemically elicited, seizure 
response, two inbred strains of Mus with varying degrees of 
audiogenic seizure susceptibility and an autosomal recessive 
audiogenic seizure-susceptible mutant of the deermouse 
Peromyscus maniculatus bairdii [1,4] were compared by de- 
termining the levels of their cerebral HMT activity. In view 
of the dissimilar distribution of HMT and of another methyl- 
transferase, catechol-O-methyltransferase, (COMT) through- 
out a number of  (rat) brain structures [11], the activity of 
cerebral  COMT was also compared between seizure-sus- 
ceptible (SS) and -resistant (SR) animals. Furthermore,  since 
the methylated products formed via HMT and COMT action 
undergo oxidative deamination by monoamine oxidases 
(MAO), the A and B forms of  this enzyme activity were also 
determined in the Mus and Peromyscus brains. 
Animals 
Males of the DBA/2J and C57BI/6J inbred strains and the 
mutant epileptic (epep) Peromyscus used throughout the 
study were obtained from stocks maintained at the Mamma- 
lian Genetics Center of  the University of  Michigan, Ann Ar- 
bor, Michigan. The wild-type, SR (EpEp) deermice were 
wild-conceived animals obtained from Dr. L. Masters, 
Museum of  Zoology, University of Michigan, Ann Arbor,  
MI. The animals received "Teklan  4% mouse and rat diet"  
and water ad lib and were housed in stainless steel cages, 
1-6/cage. 
The DBA/2J mice were examined at 21 days of  age, the 
peak of  audiogenic seizure susceptibility and intensity [17] 
and at 70 days by which time they have become SR. 
C57BI/6J mice, generally SR at all ages [17], were compared 
to the DBA/2J mice at 21 and 70 days,  as "negat ive con- 
t rois ."  The SS deermice were derived from homozygous 
matings (epep × epep) and were tested individually for clonic 
or tonic seizure response at least once after weaning using 
the key-jingling procedure of  Barto [1]. The epep animals 
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were compared to the wild-type EpEp P e r o m y s c u s  who are 
generally SR at all ages [1,4] 
METHOD 
The activities of HMT, COMT, and MAO, types A and B 
were determined by the procedures of Schatz and Sellinger 
[15], Porcher and Heller [11], and Owen et al. [10], respec- 
tively. Protein was determined according to Lowry et al. [8]. 
Enzyme activity is expressed as specific activity in nmoles of 
product/h/rag of protein. Closely analogous results were ob- 
tained by expressing the data in nmoles/hr/g of wet tissue 
(not shown). HMT was determined on whole brain homoge- 
nates and on high-speed supernatants prepared by centrifug- 
ing 1:10 (w/v) homogenates in 0.25 M sucrose at 104,000×g 
for 30 min. It has been previously demonstrated [19] that, in 
Swiss-Webster mice approximately 50% of the homogenate 
HMT activity is recovered in the high-speed supernatant. It 
should be noted that all enzyme activities were determined 
on tissue samples obtained from individual brains. 
The statistical significance was determined using Stu- 
dents t-test and the 0.05 level of significance was selected 
using the "two-tailed" test. 
RESULTS AND DISCUSSION 
Results of a survey of HMT activity in the brains of 
DBA/2J and C57B1/6J mice at 21 and 70 days are illustrated 
in Table 1. The supernatant HMT value of the SS DBA/2J 
mice at 21 days of age was significantly lower than that of the 
SR DBA/2J mice at 70 days, but not significantly different 
from that of the SR C57B1/6J mice at 21 days. Furthermore, 
while there was a significant increase in HMT activity levels 
between the 21- and 70-day old animals within each strain, 
there was no significant difference between the HMT values 
of the DBA/2J and C57BI/6J mice at either 21 or 70 days. 
There was no significant difference in the homogenate of 
21-vs 70-day old DBA/2J mice (data not shown). 
As illustrated in Table 2, the specific activity of HMT was 
consistently lower in the SS P e r o m y s c u s  than in the com- 
parable SR P e r o m y s c u s  animals whether tested in the 
homogenate or in the high-speed supernatant. Complemen- 
tary data for M u s  regarding COMT and MAO, types A and 
B, are shown in Table 3. The DBA/2J animals exhibited sig- 
nificantly lower COMT values than the C57B1/6J mice at 
both 21 and 70 days, confirming the work of Schlesinger et 
TABLE 1 
CEREBRAL HISTAMINE N-METHYLTRANSFERASE IN DBA/2J AND 
C57BI/rJ MICE* 
Mouse Strain Age, days 
21 70 
DBA/2J 5.66 _+ 0.451 6.78 -+ 0,10 z 
C57BI/6J 5.48 _+ 0.103 6.33 _+ 0.174 
*nmoles product/hr/mg protein of mean + SEM assayed in super- 
natant fraction in 4-6 animals. The following comparisons were sig- 
nificantly different at p<0.05:1 vs  2, 3 vs  4. 
TABLE 2 
CEREBRAL HISTAMINE N-METHYLTRANSFERASE IN THE 
AUDIOGENIC SEIZURE-SUSCEPTIBLE (SS) vs RESISTANT (SR) 
Peromyscus 
Fraction SS SR 
Homogenate 1.66 +_ 0.11 1.97 _+ 0.08t 
Supernatant 5.56 +_ 0.38 6.64 _+ 0.17t 
*nmoles product/hr/mg protein of mean - SEM in 6-7 sixty 
day-old animals. 
*denotes significance at p <0.05, relative to SS animals. 
al. [18]; there was, however, no significant difference in the 
DBA/2J mice at 21 vs 70 days. Table 3 shows that MAO, 
type B (substrate phenylethylamine) was also significantly 
lower in the brains of the 21-day old SS DBA/2J mice when 
compared to either 21-day old SR C57B1/6J or 70-day old SR 
DBA/2J animals. It should be noted, however, that there was 
no significant age-related difference in MAO, type B activity 
in the C57BI/6J mice. Table 3 also shows a difference in the 
specific activity of MAO, type A between 21- and 70-day old 
DBA/2J mice. This observation is to be compared to the 
findings of Schlesinger et al. [18] who reported no difference 
in the activity of cerebral 5-hydroxytryptamine-preferring 
(MAO, type A) enzyme between C57BI/6J and DBA/2J mice 
and of Kellogg [6] who described significantly higher MAO, 
type A values in 21-day old SR C57B1/6J mice relative to 
DBA/2J SS mice of the same age. 
TABLE 3 
CEREBRAL CATECHOL-O-METHYLTRANSFERASE (COMT) AND 
MONOAMINE OXIDASE (MAO), TYPES A AND B IN DBA/2J AND C57Bl/6J MICE* 
Age, 
Mouse strain days COMT MAO, type A MAO, type B 
DBA/2J (SS) 21 1.72 _+ 0.031 1.68 -+ 0.515 4.04 _+ 0.127 
C57BI/6J (SR) 21 2.41 -+ 0.01 z n.d. 4.98 _+ 0.37 s 
DBA/2J (SR) 70 1.60 _+ 0.05 ~ 13.7 _+ 0.50 e 5.02 + 0.329 
C57B1/6J (SR) 70 2.14 _+ 0.034 n.d. 4.09 - 0.31TM 
*nmoles product/hr/mg of protein of mean _+ SEM in 4-6 animals per group. 
The following comparisons were significantly different at p<0.05:1 vs 2; 1 vs 
4 ; 2 v s 4 ; 3 v s 2 ; 3 v s 4 ; 5 v s 6 ; 7 v s 8 ; 7 v s 9 .  
SS: seizure-susceptible. 
SR: seizure-resistant. 
n.d.: not determined. 
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T A B L E  4 
CEREBRAL CATECHOL-O-METHYLTRANSFERASE (COMT) AND 
MONOAMINE OXIDASE (MAO), TYPES A AND B IN SS AND SR 
eeromyscus * 
Animal COMT MAO, type A MAO, type B 
SR 1.81 ___ 0.04 (7) 15.4 ___ 0.98 (8) 6.02 + 0.36 (9) 
SS 2.71 ___ 0.10 (6)t 16.6 _+ 1.23 (7) 5.55 _+ 0.45 (8) 
*nmoles product/hr/mg of protein of mean _+ SEM. Animals were 
60 days old. 
tDenotes a significant difference at p<0.05. The numbers in pa- 
renthesis refer to the number of animals. 
The  activit ies o f  COMT,  M A O ,  type A and type B in 
P e r o m y s c u s  brain (Table 4) indicate a significant e levat ion of  
C O M T  in the SS animal and no evident  difference in ei ther  
type of  MAO.  
To summarize ,  we repor t  significantly lower  H M T  activi- 
t ies in the brains o f  two different SS animal models  and a 
significantly higher C O M T  activity in the SS than in the SR 
P e r o m y s c u s  brain. In addition, we demons t ra te  that the ac- 
t ivi ty of  cerebral  MAO,  type B, the enzyme  responsible  for 
the convers ion  of  cerebral  3-methylhis tamine to 
3-methyl imidazoleacet ic  acid [5,21] is significantly lower  in 
the 21-day old SS DBA/2J  mice than in the 70-day old SR 
animals.  
It should be noted that within M u s  and P e r o m y s c u s  there 
are different genetic models  o f  seizure susceptibili ty [7, 9, 
17, 20]. The mult iformity of  results  obtained when  data is 
compared  across  different seizure models  may thus be re- 
f lect ive of  the genetic  diversi ty ev ident  in the inherited 
epilepsies.  A similar mult iformity o f  results exists  within the 
l i terature o f  non-inheri ted,  electr ical ly or  chemical ly  elicited 
seizures [22]. Our  demonst ra t ion  of  abnormali t ies  of  cerebral  
methyl  group t ransfer  react ions in both a chemical ly  induced 
(MSO) and a genetical ly der ived seizure state (audiogenic 
seizures in P e r o m y s c u s )  should greatly facilitate the search 
to understand the relationships be tween  biochemical  and ge- 
netic mechanisms of  seizure susceptibili ty.  Work  is in prog- 
ress to further  elucidate the nature of  cerebral  methylat ion 
react ions in P e r o m y s c u s  as they may relate to this trait. 
ACKNOWLEDGMENT 
This research was supported by grant NINCDS-06294 from the 
United States Public Health Service. 
R E F E R E N C E S  
1. Barto, E. Tests for independence of "waltzer" and " e p "  
sonogenic convulsions from certain other genes in the deer- 
mouse Peromyscus maniculatus. Contr. Lab. vertebr. Biol. 
Univ. Mich. 74: 1-15, 1956. 
2. Consroe, P. and H. L. Edmonds. Genetic animal models of 
epilepsy. Fedn Proc. 38: 2397-2398, 1979. 
3. Dainat, J., C. E. Salas and O. Z. Sellinger. Alteration of the 
specificity of brain tRNA methyltransferases and of the pattern 
of brain tRNA methylation in vivo by methionine sulfoximine. 
Biochem. Pharmac. 27: 2655-2658, 1978. 
4. Doyle, R. L. The Role o f  Biogenic Amines in an Audiogenic 
Seizure-prone Genotype o f  Perornyscus Maniculatus, With an 
Analysis o f  the Protective Effects o f  Phenobarbital and 
Diphenylhydantoin. Ph.D. Dissertation, University of Michi- 
gan, 1978, pp. 1-69. 
5. Hough, L. B. and E. F. Domino. Tele-methylhistamine oxida- 
tion by type B monoamine oxidase. J. Pharmac. exp. Ther. 208: 
422--428, 1979. 
6. Kellogg, C. Serotonin metabolism in the brains of mice sensitive 
or resistant to audiogenic seizures. J. Neurobiol. 2: 209-219, 
1971. 
7. King, J. Biology o f  the Peromyscus. Society of Mammalogists 
Publication No. 10., 1968. 
8. Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J. Randall. 
Protein measurement with the Folin reagent. J. biol. Chem. 193: 
265-275, 1951. 
9. Noebels, J. L. Analysis of inherited epilepsy using single locus 
mutations mice. Fedn Proc. 38: 2405-2410, 1979. 
10. Owen, F., R. C. Bourne, J. C. K. Lai and K. Williams. The 
heterogeneity of monoamine oxidase in distinct populations of 
rat brain mitochondria. Biochern. Pharmac. 26: 289-292, 1977. 
11. Porcher, W. and A. Heller. Regional development of catechol- 
amine biosynthesis in rat brain. N. Neurochem. 19: 1917-1930, 
1972. 
12. Saavedra, J. M., M. J. Brownstein and M. Palkovits. Distribu- 
tion of catechol-O-methyltransferase, histamine N-methyltrans- 
ferase and monoamine oxidase in specific areas of the rat brain. 
Brain Res. 118: 152-156, 1976. 
13. Salas, C. E., W. G. Ohlsson and O. Z. Sellinger. The stimula- 
tion of cerebral N2-methyl and N22-dimethylguanine-specific 
tRNA methyltransferase by methionine sulfoximine: an in vivo 
study. Biochem. biophys. Res. Commun. 76:1107-1115, 1977. 
14. Schatz, R. A. and O. Z. Sellinger. Effect of methionine and 
methionine suiphoximine on rat brain S-adenosyl-L-methionine 
levels. J. Neurochem. 24: 63-66, 1975. 
15. Schatz, R. A. and O. Z. Sellinger. The elevation of cerebral 
histamine N- and catechol-O-methyltransferase activities by 
L-methionine-dl-sulfoximine. J. Neurochem. 25: 73-78, 1975. 
16. Schatz, R. A., K. Frye and O. Z. Sellinger. Increased in vivo 
methylation of a(H) histamine in the methionine sulfoximine 
epileptogenic mouse brain. J. Pharmac. exp. Ther. 207: 794- 
800, 1978. 
17. Schlesinger, K. and B. J. Griek. The genetics and biochemistry 
of audiogenic seizures. In: Contribution to Behavior-Genetic 
Analysis: The Mouse as a Prototype, edited by G. Lindzey and 
D. D. Thiessen. New York: Appleton-Century-Crofts, 1970, pp. 
219-259. 
18. Schlesinger, K., J. Harkings, B. S. Deckard and C. Paden. 
Catechol-O-methyltransferase and monoamine oxidase activi- 
ties in brains of mice susceptible and resistant to audiogenic 
seizures. J. Neurobiol. 6: 587-596, 1975. 
19. Sellinger, O. Z., R. A. Schatz and W. G. Ohlsson. Rat and 
mouse brain histamine N-methyltransferase: modulation by 
methylated indoleamines. J. Neurochem. 30: 437-445, 1978. 
20. Seyfried, T. N. Audiogenic seizure in mice. Fedn Proc. 38: 
2399-2404, 1979. 
21. Waldmeier, P. C., J. J. Feldtrauer and L. Maitre. Methylhis- 
tamine: evidence for selective deamination by MAO B in the rat 
brain in vivo. J. Neurochem. 29: 785-790, 1977. 
22. Woodbury, D. M. Convulsant drugs: Mechanisms of action. In: 
Antiepileptic Drugs, Mechanisms o f  Action, edited by G. H. 
Glaser, J. K. Penry and D. M. Woodbury. New York: Raven 
Press, 1980, pp. 249-302. 
